Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy: Interim Results from the Noninterventional NORA Study
Eur Urol Focus 2021 Dec 23;[EPub Ahead of Print], MO Grimm, V Grünwald, H Müller-Huesmann, P Ivanyi, M Schostak, E von der Heyde, W Schultze-Seemann, H Belz, M Bögemann, M Wang, M Herber, J BedkeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.